Study identification

PURI

https://redirect.ema.europa.eu/resource/41151

EU PAS number

EUPAS39679

Study ID

41151

Official title and acronym

COVID-19 vaccine effectiveness at primary care level in Europe: generic protocol (I-MOVE-COVID primary care VE)

DARWIN EU® study

No

Study countries

France
Ireland
Netherlands
Portugal
Spain
Sweden
United Kingdom (Northern Ireland)

Study description

Multicentre European test-negative design at primary care level, measuring COVID-19 vaccine effectiveness

Study status

Planned
Research institution and networks

Institutions

EpiConcept
First published:
01/02/2024
Institution

Networks

Contact details

Esther Kissling

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:

Study start date

Planned:

Date of final study report

Planned:
Sources of funding
EU institutional research programme
Other

More details on funding

European Commission, Public Health National institutes
Study protocol
Initial protocol

I-MOVE-COVID-19 primary care COVID-19 vaccine effectiveness protocol v2.2

English (937.65 KB - PDF)View document
Updated protocol

I-MOVE-COVID-19 primary care COVID-19 vaccine effectiveness protocol v2.3

English (926.99 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable